UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008871
Receipt number R000010410
Scientific Title clinical study of positron emission tomography with 3-deoxy-3-[18F]-fluoro-D-glucose
Date of disclosure of the study information 2012/09/07
Last modified on 2019/03/12 21:32:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

clinical study of positron emission tomography with 3-deoxy-3-[18F]-fluoro-D-glucose

Acronym

Clinical study in 3FDG-PET

Scientific Title

clinical study of positron emission tomography with 3-deoxy-3-[18F]-fluoro-D-glucose

Scientific Title:Acronym

Clinical study in 3FDG-PET

Region

Japan


Condition

Condition

healthy adult volunteer,
cancer, epilepsy, Moyamoya disease,Alzheimer's disease

Classification by specialty

Hematology and clinical oncology Neurology Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

evaluation of the effectiveness of clinical diagnosis in 3FDG-PET

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

visualization of the lesion

Key secondary outcomes

Confirmation of the differences between 3FDG-PET and conventional 2FDG-PET


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

MRI/CT/EEG/clinical examinations

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

healthy volunteers between 20 and 70 years cognitive normal subjects without severe physical complication

patients with cancer diagnosis between 20 and 70 years

Key exclusion criteria

exclude the patients who are recognized as
inadequate patients by doctors with
resposibility in this study

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tsutomu Nakada

Organization

University of Niigata
Brain Research Institute

Division name

Center for Integrated Human Brain Science

Zip code


Address

Asahimachi 1-757, Chuo-ku,Niigata

TEL

025-227-0683

Email

tnakada@bri.niigata-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yuji Suzuki

Organization

University of Niigata

Division name

Center for Integrated Human Brain Science

Zip code


Address

Asahimachi 1-757, Chuo-ku,Niigata

TEL

025-227-0683

Homepage URL


Email

yuji-s@bri.niigata-u.ac.jp


Sponsor or person

Institute

Center for Integrated Human Brain Science,
Brain Research Institute, University of Niigata

Institute

Department

Personal name



Funding Source

Organization

grant from Ministry of Education, Culture, Sports, Science

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 09 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 09 Month 06 Day

Date of IRB

2007 Year 07 Month 04 Day

Anticipated trial start date

2012 Year 09 Month 07 Day

Last follow-up date

2019 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 09 Month 06 Day

Last modified on

2019 Year 03 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010410


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name